KeyCorp CapEx decreased by 73.3% to $12.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.0%, from $10.00M to $12.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 12.4% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.00M | $0.00 | $35.00M | $18.00M | $24.00M | $19.00M | $35.00M | $24.00M | $50.00M | $25.00M | $43.00M | $12.00M | $13.00M | $17.00M | $23.00M | $10.00M | $23.00M | $29.00M | $45.00M | $12.00M |
| QoQ Change | — | -100.0% | — | -48.6% | +33.3% | -20.8% | +84.2% | -31.4% | +108.3% | -50.0% | +72.0% | -72.1% | +8.3% | +30.8% | +35.3% | -56.5% | +130.0% | +26.1% | +55.2% | -73.3% |
| YoY Change | — | — | — | — | +20.0% | — | +0.0% | +33.3% | +108.3% | +31.6% | +22.9% | -50.0% | -74.0% | -32.0% | -46.5% | -16.7% | +76.9% | +70.6% | +95.7% | +20.0% |